Trial intelligence / Profile preview

Interoceptive fear conditioning with pentagastrin or inspiratory load and CO2 in healthy adults

NL-OMON20198Recruiting

Sponsor
Maastricht University
Start
Dec 2010
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Trial of pentagastrin (2 arms), sponsored by Maastricht University. Primary endpoint: Subjective fear during test phase. Started Dec 2010; status: recruiting.

02

Drugs

pentagastrin

Beyond the preview

Go deeper on NL-OMON20198.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20198.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call